A new type of blood–brain barrier aminoacidopathy underlies metabolic microcephaly associated with SLC1A4 mutations
Brain · 04.11.2024 · 147 (11) · 3874-3889
DOI: 10.1093/brain/awae134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 25.04.2024. Verfasst von Maali Odeh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Inst of Technology, Haifa 3109601, Israel. Hauptthemen laut MEDLINE: Microcephaly, Blood-Brain Barrier, Mutation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Israel Ministry of Health, COST Action 19105-Pan-European Network in Lipidomics and EpiLipidomics, NICHD NIH HHS.
Abstract (Originalsprache)
Mutations in the SLC1A4 transporter lead to neurodevelopmental impairments, spastic tetraplegia, thin corpus callosum and microcephaly in children. SLC1A4 catalyses obligatory amino acid exchange between neutral amino acids, but the physiopathology of SLC1A4 disease mutations and progressive microcephaly remain unclear. Here, we examined the phenotype and metabolic profile of three Slc1a4 mouse models: a constitutive Slc1a4-knockout mouse; a knock-in mouse with the major human Slc1a4 mutation (Slc1a4-K256E); and a selective knockout of Slc1a4 in brain endothelial cells (Slc1a4tie2-cre). We show that Slc1a4 is a bona fideL-serine transporter at the blood–brain barrier (BBB) and that acute inhibition or deletion of Slc1a4 leads to a decrease in serine influx into the brain. This results in microcephaly associated with decreased L-serine content in the brain, accumulation of atypical and cytotoxic 1-deoxysphingolipids, neurodegeneration, synaptic and mitochondrial abnormalities and behavioural impairments. Prenatal and early postnatal oral administration of L-serine at levels that replenish the serine pool in the brain rescued the observed biochemical and behavioural changes. Administration of L-serine until the second postnatal week also normalized brain weight in Slc1a4-E256K mice. Our observations suggest that the transport of ‘non-essential’ amino acids from the blood through the BBB is at least as important as that of essential amino acids for brain metabolism and development. We propose that SLC1A4 mutations cause a BBB aminoacidopathy with deficits in serine import across the BBB, required for optimal brain growth, leading to a metabolic microcephaly, which may be amenable to treatment with L-serine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Inst of Technology, Haifa 3109601, Israel.
- Institute of Clinical Chemistry, University of Zurich and University Hospital Zurich, Zurich 8091, Switzerland.
- Department of Occupational Therapy, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa 3498838, Israel.
- Electron Microscopy Unit, B. Rappaport Faculty of Medicine, Technion-Israel Inst of Technology, Haifa 3109601, Israel.
- Sonoworx Co., Haifa 3473113, Israel.
- Biosense Webster, Yokneam 2066717, Israel.
ORCID-Profile: Thorsten Hornemann, Daniel J Liebl
Förderung
- Israel Ministry of Health
- COST Action 19105-Pan-European Network in Lipidomics and EpiLipidomics
- NICHD NIH HHS
- NIH HHS
- European Joint Program on Rare Diseases
- NINDS NIH HHS
- Laura and Isaac Perlmutter Metabolomics Center
- Allen and Jewel Prince Center for Neurodegenerative Diseases
Zitieren
APA
Odeh, M., Sajrawi, C., Majcher, A., Zubedat, S., Shaulov, L., Radzishevsky, A., Mizrahi, L., Chung, W. K., Avital, A., Hornemann, T., Liebl, D. J., Radzishevsky, I., & Wolosker, H. (2024). A new type of blood–brain barrier aminoacidopathy underlies metabolic microcephaly associated with SLC1A4 mutations. Brain, 147(11), 3874-3889. https://doi.org/10.1093/brain/awae134
Vancouver
Odeh M, Sajrawi C, Majcher A, Zubedat S, Shaulov L, Radzishevsky A, et al. A new type of blood–brain barrier aminoacidopathy underlies metabolic microcephaly associated with SLC1A4 mutations. Brain. 2024;147(11):3874-3889. doi:10.1093/brain/awae134
BibTeX
@article{Odeh2024,
author = {Odeh, Maali and Sajrawi, Clara and Majcher, Adam and Zubedat, Salman and Shaulov, Lihi and Radzishevsky, Alex and Mizrahi, Liron and Chung, Wendy K and Avital, Avi and Hornemann, Thorsten and Liebl, Daniel J and Radzishevsky, Inna and Wolosker, Herman},
title = {A new type of blood–brain barrier aminoacidopathy underlies metabolic microcephaly associated with SLC1A4 mutations},
journal = {Brain},
year = {2024},
volume = {147},
number = {11},
pages = {3874--3889},
doi = {10.1093/brain/awae134}
}
EUVIMED